Hello, Welcome to Shine Consultant !
Summit & Event Shine Speaker Bureau Shine Advisor Shine Event Service
  • Summit & Event
    Summit & Event ：
    With field research of markets and industries which is analyzed from a global strategic perspective by our professional teams, as well as hot topics which interest leadership and management, Shine Consultant provides you with one-stop platform of dialogue, practice -sharing and social network!
    Learn More>
    Wealth & Capital Management
    Insurance & Finance
    Healthcare & Pharma
    Retail & FMCG
    Travel & Transportation
  • Shine Speaker Bureau
    Shine Speaker Bureau：
    Committed to provide keynote speakers, executive learning masterclasses and boardroom advisory for global enterprises and institutions, each service provides a deeper and more interactive experience, especially for small, selected audiences and key individuals. We have the resources of the most influential business leaders and experts, who are the most outstanding representatives in their fields. Our team consists of experienced speech and event managers, and we focus on building long-term and in-depth partnerships.
    Learn More>
    The Leader Networks
    Advisor
    Think-Tank
  • Shine Advisor
    Shine Advisor：
    As world-class insight network, we connects clients-decision makers with vetted subject matter experts-advisors. Our clients leverage the insights and perspectives shared by our advisors to stay informed and make better business decisions.We have over 600,000 Shine Advisors in 20 industries, which continues to grow every day.
    Learn More>
    Briefing
    Consensus
    Customized Research
  • Shine Event Service
    Shine Event Service：
    Committed to be the world's most professional provider of industrial Summit & Event. We provide one-stop professional services, including investigating and planning, on-demand inviting, marketing and promoting, operating, project management, live& digital conference, each service is performed by an experienced professional team matched with long-term industrial resources. We focus on establishing long-term and in-depth partnerships.
    Learn More>
Guest Information
Nanding ZHAO
Nanding ZHAO
Positions：

Deputy General Manager
Company：

Hefei SARI Oborgen Biopharma Co., Ltd.

Nanding Zhao has been Deputy General Manager of Hefei SARI Oborgen Biopharma Co., Ltd since April 2019 participating managing the innovative Italian oncology R&D company Nerevian Medical Sciences (NMS) Group. Before Hefei SARI Oborgen, he was CEO position of Suzhou Kanova Biopharmaceutical Co., Ltd.(2018.7-2019.4), and Head of External Innovation from 2015-2018 at China Novartis Institutes for BioMedical Research Co., Ltd. (CNIBR), respectively. Before his career at CNIBR he was Associate Director, External Research of Oncology PCU at Eisai, Inc. USA, a subsidiary of Japanese pharmaceutical company Eisai, Co., Ltd. He was with Eisai for 17+ years where he held various positions from leading to managing drug discovery projects of anti-inflammatory and anticancer. Between 2009-2015 he led external collaboration initiatives to support Eisai Oncology PCU US preclinical operations and managed external collaborations with various aspects, from fee-for-services, contract research, business development and strategic alliance management. Collaboration partners encompassed CROs in China, US, Europe and Japan, academic institutions of US and Japan, governmental agency (NIH/NCI), and biotech and pharma companies. At CNIBR he lead a group with similar mission to support R&D pipeline and projects.

 

Nanding earned his B.S. & M.S. degrees in Microbiochemistry from Chiba University Faculty of Pharmaceutical Sciences (Chiba, Japan), and a Doctor of Science degree in Molecular Biology and Medicine from Kyushu University Graduate School of Medical Sciences (Fukuoka, Japan) under the supervision of Dr. Yoshiyuki Sakaki, former Chairman of Human Genome Organization which led and managed the Human Genome Project. He then conducted three-year post-graduate research from 1994-1997 at The Section of Hematology/Oncology, The University of Chicago Pritzker School of Medicine (Chicago, IL, USA) under Dr. Michelle M. Le Beau, director of the University of Chicago Medicine Comprehensive Cancer Center and the Arthur and Marian Edelstein Professor of Medicine and director of the Cancer Cytogenetics Laboratory at the University of Chicago where he was promoted to Instructor (Research Associate) at the end of the training. He also holds an MBA degree from Boston University Graduate School of Management (Boston, MA, US) with certificate in Healthcare Management.